Lv4
740 积分 2022-09-28 加入
Antibody–Drug Conjugates for Immunology
2天前
已完结
DB-2304, a Duality Immune Modulating Antibody‒Drug Conjugate (DIMAC) targeting BDCA2, displays strong potency in the suppression of pDC functions
2天前
求助中
Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand?
2天前
已完结
Antibody–drug conjugates come of age in oncology
12天前
已完结
Approaches to Improve the Translation of Safety, Pharmacokinetics and Therapeutic Index of ADCs
13天前
已完结
Antibody-mediated co-delivery of programmable drug combinations
19天前
已完结
Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies
1个月前
已完结
Translational PK/PD framework for antibody-drug conjugates to inform drug discovery and development
1个月前
已完结
Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys
1个月前
已完结
Pharmacokinetics and pharmacodynamics of antibody-drug conjugates for the treatment of patients with breast cancer
1个月前
已完结
皖公网安备34019202002308
